The first study that assigned BRCA2 to the FA complementation group D1 (Table 1) was based on two BRCA2 homozygous patients with classical FA pathologies, including congenital abnormalities, abnormal skin pigmentation and cellular sensitivity to MMC (Howlett et al, 2002). This evidence concerns the gene BRCA2 and Friedreich ataxia.